Skip to main content
. 2019 Aug 30;11(9):1279. doi: 10.3390/cancers11091279

Table 1.

Clinico-pathological features and main molecular data of 16 IDH-wt GBMS in adult patients younger than 55 years. Cases are ordered by increasing TML.

Case Gender Age Site OS (months) IDH1/2 EGFR ATRX TP53 PTEN TML MMR Genes
4 GL M 49 fronto-temporal right DOD (11) wt ampl 5.28
6 GL M 41 fronto-temporal right DOD (3) wt ampl 5.66
2 GL F 49 temporo-parietal left DOD (46) wt ampl/mut 6.34
15 GL M 43 fronto-basal DOD (14) wt mut 6.47
16 GL M 40 temporal left DOD (9) wt mut 7.12
7 GL M 39 temporo-parieto-occipital left DOD (14) wt ampl 7.33
13 GL F 41 temporal left Alive (24) wt ampl 7.75
9 GL M 18 temporo-parietal left Alive (38) wt mut mut 8.22
11 GL F 29 cerebellar right DOD (15) wt 9.24
10 GL M 43 frontal DOD (15) wt mut mut 10.1
8 GL M 46 temporo-parietal left Alive (41) wt mut 12.35
1 GL F 47 temporo-parieto-occipital right Alive (23) wt mut mut 13.07 MLH1 mut *
14 GL M 43 frontal lobe Alive (14) wt mut 14.34
3 GL M 24 temporal left Alive (24) wt ampl/mut mut 43.19
12 GL M 39 frontal Alive (32) wt mut mut 168.02 MSH6 mut
5 GL F 37 frontal Alive (79) wt mut mut 219.79 MSH2 mut

OS: overall survival. DOD: died of disease. TML: tumour mutation load. MMR: mismatch repair. F: female. M: male. Ampl: amplified. Mut: mutation. * Classified as benign in the PolyPhen Database.